Infections that were once easy to cure with antibiotics are becoming untreatable, and a novel treatment for bacterial infection is the holy grail for teams of researchers around the world.
The impact of antimicrobial resistance is asymmetrical; while it affects everyone, low and middle-income countries bear a far greater burden, particularly in sub-Saharan Africa.
The death rate caused by drug-resistant bacteria reached 1.27 million in 2019, and economic costs are projected to exceed $1 trillion by 2030.
Global leaders will meet to discuss AMR and seek ways to incentivize researchers and companies to create new antibiotics and improve access to treatments.
#antimicrobial-resistance #public-health #drug-resistant-infections #global-health #pharmaceutical-industry
[
Collection
]
[
|
...
]